Immune Checkpoint Inhibitor Side Effects: Rising Incidence, Stable Mortality & High-Risk Events

The landscape of cancer treatment has been dramatically altered in recent years by the advent of immunotherapy, specifically through the use of immune checkpoint inhibitors (ICIs). These therapies, while offering significant hope for improved prognoses, are not without risk. A recent international study has highlighted the increasing frequency of adverse events (AEs) associated with ICIs, … Read more

New Daily HIV Pill Simplifies Treatment for Patients with Resistance | Bictegravir & Lenacapavir

Berlin – A new once-daily single-tablet regimen combining bictegravir and lenacapavir is showing promise as a simplified treatment option for people living with HIV who have complex antiretroviral therapy (ART) regimens. Results from the Phase 3 ARTISTRY-1 trial, published today in The Lancet, demonstrate that switching to the bictegravir-lenacapavir combination maintains virologic suppression with a … Read more

Omeprazole and Gastric Cancer Risk: What You Need to Know

:## Analysis of ⁤the Provided Text 1. Core topic &‍ Intended ⁢Audience: The core topic of ⁢the text is a recent⁢ study‍ investigating the long-term relationship between proton pump inhibitor (PPI)⁤ use and the risk of gastric adenocarcinoma (stomach cancer). It addresses concerns raised by ⁤previous research suggesting a ‍potential link between PPIs and‍ increased … Read more

Brain ‘Off Switch’ for Pain Found in New Study | Health & Wellbeing or Pain Relief Breakthrough: Scientists Identify Brain Mechanism with No Side Effects or New Research Pinpoints Brain Area to Stop Pain Without Side Effects

Chronic pain affects⁣ millions, and recent breakthroughs ⁤offer a new⁣ perspective on how⁤ we might address it, moving beyond simply masking symptoms.For years, the focus ⁣has been on blocking pain signals, but emerging research suggests a more nuanced approach – one ⁣that retrains the ‍brain’s response too discomfort. This shift is particularly vital given the … Read more